SHILPAMED.NSSHILPAMED.NSNSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank93
3Y CAGR+14.2%
5Y CAGR+45.0%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+14.2%/yr
vs +11.4%/yr prior
5Y CAGR
+45.0%/yr
Recent deceleration
Acceleration
+2.8pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 81.75 | -39.4% |
| 2024 | 134.85 | +320.8% |
| 2023 | -61.06 | -211.3% |
| 2022 | 54.85 | +197.8% |
| 2021 | 18.41 | +44.2% |
| 2020 | 12.77 | -47.7% |
| 2019 | 24.42 | -31.4% |
| 2018 | 35.60 | -22.9% |
| 2017 | 46.16 | +51.5% |
| 2016 | 30.46 | - |